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Introduction
Small RNA sequences can exhibit a wide range of interesting 
cellular functions, including those found to occur naturally 
in cells and those engineered for therapeutic or experimental 
intervention.1-4 The problem of delivering intact RNA to cells, 
however, continues to delay realization of the potential of 
small RNA therapeutics.5,6 The instability of unmodified small 
RNA and the additional cost and difficulty of chemical RNA 
synthesis, compared with DNA synthesis,7 add to the difficulties 
of using small RNA in therapeutic applications. In comparison, 
DNA oligonucleotides are simpler to make, more stable in 
biological f luids than RNA, and can carry the same sequence 
information. Converting DNA sequence information into RNA 
however requires comparatively large transcriptional promoters 
integrated into viral or plasmid vectors, an impediment that 
prevents the use of the more easily synthesized and more stable 
synthetic DNA.
We are developing promoterless transcription vectors made 
from the template strand of the cDNA encoding a desired small, 
usually hairpin, RNA. We have found that, in circularized form, 
and with certain sequence and secondary structure features, 
RNA polymerase III (RNAP III) can use such templates to make 
discrete transcripts in human cells and cell extracts.8 We refer 
to these chemically synthesized vectors as coligos, for circular 
oligonucleotides. Circularization imparts resistance to cellular8 
and serum9 exonucleases, and appears to be structurally required for 
productive transcription, perhaps through stabilizing a template 
secondary structure that mimics a natural intermediate on the 
pathway of promoter-based transcription.8 To establish the extent 
of their usefulness, it will be necessary to understand the sequence 
and structural features that determine transcription by RNAP 
III, including initiation, termination and possible processing 
by cellular ribonucleases. Since in vitro coligo transcription 
appears to faithfully represent the intracellular transcription of 
coligos in transfected cells,8 we herein make use of two in vitro 
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chemically synthesized DNa can carry small RNa sequence information but converting that information into small 
RNa is generally thought to require large double-stranded promoters in the context of plasmids, viruses and genes. 
We previously found evidence that circularized oligodeoxynucleotides (coligos) containing certain sequences and 
secondary structures can template the synthesis of small RNa by RNa polymerase III in vitro and in human cells. By using 
immunoprecipitated RNa polymerase III we now report corroborating evidence that this enzyme is the sole polymerase 
responsible for coligo transcription. The immobilized polymerase enabled experiments showing that coligo transcripts 
can be formed through transcription termination without subsequent 3′ end trimming. To better define the determinants 
of productive transcription, a structure-activity relationship study was performed using over 20 new coligos. The results 
show that unpaired nucleotides in the coligo stem facilitate circumtranscription, but also that internal loops and bulges 
should be kept small to avoid secondary transcription initiation sites. a polymerase termination sequence embedded in 
the double-stranded region of a hairpin-encoding coligo stem can antagonize transcription. Using lessons learned from 
new and old coligos, we demonstrate how to convert poorly transcribed coligos into productive templates. Our findings 
support the possibility that coligos may prove useful as chemically synthesized vectors for the ectopic expression of 
small RNa in human cells.
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transcription systems—one using whole cell extract (WCE) and 
another using RNAP III purified by immunoprecipitation (IP) 
via a stably transfected FLAG-tagged RNAP III subunit—to 
explore the initiation, elongation, termination and processing of 
coligo transcripts made by RNAP III.
Results
Coligo transcription by immunoprecipitated RNA 
polymerase III
Using the transcription inhibitor α-amanitin, against 
which the three mammalian RNA polymerases are differently 
susceptible, we previously identified RNAP III as the main and 
likely sole RNA polymerase responsible for coligo transcription 
in mammalian cells and cell extracts.8 Since RNAP III generally 
appears to circumtranscribe once around a coligo before 
terminating, rather than multiple times as do bacterial and 
bacteriophage RNA polymerases,10-12 we have found coligo-
derived transcripts laborious to sequence due to interference by 
abundant endogenous small RNA.8 To facilitate coligo transcript 
sequencing and to corroborate by a different method that RNAP 
III is the enzyme responsible for transcribing coligos, we used 
a HEK293-based cell line stably expressing a FLAG-tagged 
RNAP III F-subunit (HEK293/POLR3F).13 To evaluate the 
coligo-transcribing ability of RNAP III immunoprecipitated 
(IP’d) via this subunit, we used a variety of coligos encoding pre-
miRNA-like hairpin RNAs, and which have the general coligo 
features previously found8 to favor promoterless transcription 
(Fig. 1, structures predicted using the mfold program14). 
Specifically, the transcription start site (TSS) is predicted at a 
pyrimidine, usually flanked by purines, near the 3′ end of the 
stem-larger loop junction. Transcription termination is predicted 
to occur at or close to the 5′ end of the stem-larger loop junction. 
Where present, RNAP III termination signals15,16 are indicated in 
the figures by a line over the pentamer sequence. Total coligo size 
and predicted transcript lengths are also given.
Coligo 122 (Fig. 1), based on pre-miRNA 122, was 
previously found to be transcribed into an 83 nucleotide (nt) 
transcript encompassing the pre-miRNA.8 Immunoprecipitate 
from HEK293/POLR3F whole cell extract (WCE), but not 
that from untransfected HEK293T WCE, displayed robust in 
vitro coligo transcription activity (Fig. 2A, lanes 5 and 9). In 
vitro transcription by the FLAG-RNAP III complex appeared 
identical whether it took place on the IP beads or after elution 
using the FLAG peptide (Fig. 2B).
The pattern of in vitro transcripts from coligo 122 by IP’d 
RNAP III was very similar to the pattern produced in HEK293T 
WCE. The observation that the main ~83 nt transcript was 
Figure 1. sequence and predicted secondary structure of the coligos used in Figure 2. coligo 122 transcription start site (Tss, arrow) and transcript 
3′ end site (stop) were identified previously by cDNa sequencing.8 Tss of coligo 19am3 and 19anbm34 were predicted based on their close similarity 
to coligo 19aTAR transcript sequencing data.8 The Tss for coligos 221, luc-2, luc-1, Dcr3, and 15a-b are predicted to be at a pyrimidine close to the 3′ 
end of the DNa stem, near its junction with the larger loop. Transcript 3′ end sites, resulting from termination or termination with nuclease trimming, 
are predicted to be at the 5′ end of the DNa stem, based on previous observations.8 coligo luc-2 and luc-1 differ only by one nucleotide (circled) in the 
larger terminal loop region. shaded regions indicate cDNa of mature miRNa in those coligos designed from human genomic miRNa loci. Black triangles 
denote the 3′ and 5′ ends of the linear precursor deoxyoligonucleotides, where the sequences were ligated to form a circle. coligo sizes are shown in 
nucleotides (nt); solid lines above sequences indicate known RNaP III termination sequences.
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produced by both in vitro systems indicates that this transcript is 
formed directly by termination, rather than by post-transcriptional 
end trimming of a longer, initially formed transcript. There were 
however small differences in the overall transcript patterns. The 
Figure 2. In vitro transcription (IVT) of coligo templates by immunoprecipitated RNaP III compared with IVT in whole cell extract (Wce). (A) IVT of coligo 
122 using the RNaP III complex immunoprecipitated (IP) from heK293/POLR3F Wce or from unmodified heK293T cells. Lanes 10–18: titration of coligo 
122 shows that it reaches saturation in the IP experiments at 50–100 nM, as found previously for Wce. sup, IP supernatant. Rel. RNa, relative intensity 
of single circumtranscription (monomer) gel bands. (B) IVT of coligo 122 by IP’d RNaP III complex on beads or after elution from beads. (C) Western blot 
analysis of RNaP III subunit B (POLR3B, aka RPc2) (upper gel) and the RNaP II largest subunit RPB1 c-terminal domain (cTD) (lower two gels) in Wce and 
IP’d RNaP III. asterisk in lower gels denotes bands originating from the commercial IP beads and reacting directly with the secondary antibody. The IP 
and Wce were loaded on the gel in the same proportion as used in IVT. Bsa was used in a control IP in place of Wce. (D) IVT profiles for a set of eight 
different coligos using either heK293T Wce or IP’d RNaP III complex from heK293/POLR3F Wce. coligo sequences are shown in Figure 1. Vertical black 
lines mark a 10 nt window centered on the predicted size for monomer transcripts as specified in Figure 1 legend and in text.
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IP’d enzyme produced more apparently abortive transcripts, i.e., 
those failing to complete one circumtranscription (e.g., compare 
Fig. 2A lane 3 and Fig. 2B lane 5). Two other differences in the 
IP’d enzyme were: slightly less efficient termination, leading 
to the production of more dimer and higher order multimer 
transcripts, and the appearance of weak transcripts in between 
the main transcripts (e.g., Fig. 2A, lane 9 vs. lane 4). (Note that 
multimer transcripts appear over-represented as they have more 
incorporated label.)
Once we had established the protocol for in vitro transcription 
by IP’d RNAP III, to assess its activity we estimated the relative 
amount of the polymerase present in reactions using the 
IP’d enzyme and reactions using WCE from HEK293T and 
HEK293/POLR3F cells (Fig. 2C). Using an antibody specific 
for the RNAP III RPC2 subunit, we found that the IP’d enzyme 
contained ~5.6-fold more RPC2 per in vitro reaction than did 
the WCE reactions from either type of cells. No RNAP II 
could be detected in the RNAP III immunoprecipitate using 
an antibody against the RNAP II largest subunit C-terminal 
domain (Fig. 2C, middle and bottom) In comparison, only 
2.5-fold more coligo 122 monomer transcript was produced by 
the IP’d enzyme than by the enzyme in WCE from HEK293/
POLR3F cells (Fig. 2A), and 1.7-fold (2.5/1.5) more 122 
monomer transcript was produced by the IP’d enzyme compared 
with WCE from HEK293T cells. Since the enzyme (and not 
the template, see Figure 2A, lanes 10–18) is limiting over this 
concentration range, the IP’d enzyme appears to be slightly less 
active than the WCE enzyme on a per RPC2 subunit basis. 
This observation argues against the possibility that single-
stranded (ss) DNA-binding proteins strongly compete for, and 
reduce transcription from, 122’s larger loop in WCE, since 
their removal should have led to greater coligo transcription 
activity. In contrast, three coligos (luc-1, luc-2, Dcr3) did 
appear to show significantly increased transcription activity by 
the IP’d enzyme (Fig. 2D). These coligos also exhibited greater 
read-through and consequently greater tandem multimer 
transcript production, despite having canonical RNAP III 
termination signals. One possible interpretation is that for 
these three coligos, removing cellular proteins does increase 
RNAP III access to the larger loop and decreased termination 
by alleviating steric obstruction of the elongating polymerase. 
Thus, removing most other cellular proteins by RNAP III IP 
may for some coligos increase the activity of the polymerase, 
but this effect appears to depend on the coligo sequence. These 
observations raise the possibility that some stem-loop junction 
Figure 3. coligo termination and transcript fate after in vitro transcription. (A) schematic depiction of an experiment designed to detect coligo tran-
script fate at the end of IVT. a scaled up IVT in heK293/POLR3F Wce was divided and processed as shown. (B) DPaGe analysis of the uniformly labeled 
coligo 122 transcript after processing. small bracket on gel indicates coligo 122 monomer transcript band used for quantification; Rh, RNase h; Rh 
product, RNase h degraded transcript products; M, decade marker; sup., supernatant.
Figure  4 (see opposite page). coligos require unpaired nucleotides 
near the larger loop for successful circumtranscription. (A) sequence 
and predicted secondary structure of coligos used for IVT in Panels B, 
c, and D. Transcription start sites (Tss) and 3′ end stop sites for 19aTAR 
were previously determined.8 all other Tss, stop sites and expected 
transcript sizes are predicted based on similarity to 19aTAR, and as 
described in Figure 1 legend and in text. coligo 19anbm34 is a modi-
fied 19aTAR lacking all internal bulges and loops. The original internal 
loops and bulges of 19aTAR were incrementally re-introduced to form 
coligo 19anb-BR1 and -BR2, -BR3, -BR4, and -BR5. LL, larger terminal 
loop from coligo 19aTAR; black triangle, circularization sites; nt, nucleo-
tides. (B) heK293T Wce IVT for coligos lacking internal bulges and loops. 
Brackets mark a 10 nt window centered on the predicted size for mono-
mer transcripts using the 19aTAR initiation site. (C and D) heK293T Wce 
IVT of coligos with re-introduced internal loops and bulges from 19aTAR. 
M, marker; L, linear precursor; c, coligo. Wce, whole cell extract; IVT, in 
vitro transcription. Dashed line boxes indicate gel regions (for every lane 
in gel but shown only for the first lane) used for transcript quantification.
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sequences may favor transcription initiation by RNAP III 
more than others do, so that optimization of the larger loop for 
initiation and termination might be possible.
The transcript pattern similarities and differences between 
the endogenous and IP’d enzymes also applied to coligos 221, 
19am3, luc-2, luc-1 and Dcr3 (Fig. 2D). The main transcripts 
Figure 4. For figure legend see page 4.
e27913-6 Transcription Volume 5 
produced by endogenous RNAP III in WCE were also found in 
the transcripts produced by the IP’d enzyme. As noted above, the 
reduced termination efficiency was exaggerated for luc-1, luc-2 
and Dcr3, the same coligos that showed increased transcription. 
Overall, the results shown in Figure 2D demonstrate that, for 
a variety of coligo templates, transcription by IP’d RNAP III 
and WCE from untransfected cells produced similar though 
not always identical transcript patterns. In combination with 
the lack of detectable RNAP II in the IP’d RNAP III (Fig. 2C), 
and with the previous α-amanitin findings,8 these results provide 
corroborating evidence that RNAP III is the main and likely sole 
coligo-transcribing RNA polymerase, and that the IP’d enzyme 
complex behaves similarly to the endogenous complex.
Coligo transcript termination and release from RNAP III 
and template
Immobilizing RNAP III through the FLAG tag enabled us 
to examine whether the transcription products were released 
from the polymerase or whether transcription had merely paused 
at the time the transcripts were isolated. A scaled up in vitro 
transcription reaction was performed and divided as depicted in 
Figure 3A. Coligo transcripts were not found to be associated 
with the IP’d RNAP III (Fig. 3B, lane 5), but instead had been 
released into the supernatant, suggesting that termination had 
taken place.
It was recently found that a polyU sequence immediately 
downstream of a transcript hairpin can trigger RNAP III 
termination.15 Coligos are single-stranded and made exclusively 
from the non-coding strand of a cDNA, so might behave differently 
than ds templates. Nevertheless, we had independently noticed 
that RNAP III tends to terminate coligo transcription following 
the completion of a hairpin, rather than within a stem.8 By chance 
and by design, most of the coligos we have tested so far have had a 
RNAP III termination signal in the larger loop or near the larger 
loop-stem junction. In the two cases we have sequenced, 122 and 
19aTAR,8 termination appeared to occur either just before or 
just after the termination sequence, but not in the same position 
with respect to the termination sequence, leaving its contribution 
unclear. In the coligos depicted in Figure 1, the termination 
sequences (indicated by a solid line over the pentamer sequence) 
occur at different locations within or near the larger loop. The 
sizes of the transcripts observed correlate well with the number of 
nucleotides between the predicted TSS and the stem-larger loop 
junction (Fig. 2D, vertical lines on gel), though in some cases 
termination at the 2nd nt of the termination pentamer17 would 
create a monomer transcript of similar size. (Coligo 19anbm34 
was an exception for reasons discussed below.) Termination at 
a termination sequence followed by 3′-5′ exonuclease trimming 
too rapid to observe may be possible for some coligos (e.g., 
luc-1, luc-2, Dcr3, Fig. 2D), though as described above it is not 
universal (e.g., 122, 221, 19am3, Fig. 2D). We cannot yet be sure 
how termination depends on the coligo secondary structure and 
sequence, but suspect that termination sequences and completion 
of the hairpin stem both contribute.
The terminated transcripts from coligo 122 were also probed 
with RNase H to assess persistent hybridization between the 
transcript and coligo template. Transcript release is desirable 
because stable coligo:transcript hybrids (i) may prevent multiple 
rounds of transcription from the same coligo, (ii) may lead to 
endogenous RNase H degradation of the coligo transcripts and 
(iii) may prevent coligo transcripts from folding into functional 
RNAs. As previously found for transcripts made in WCE, 
about half of the RNA dissociated from the coligo (Fig. 3B, 
compare lanes 6 and 7), an outcome likely favored by the strong 
intramolecular base pairing in both coligo and transcript.8
Bulges and internal loops facilitate coligo transcription 
elongation
Since a hairpin appears necessary for RNAP III termination,15 
we wondered if fully base-paired intramolecular hairpin stems 
such as are found in short hairpin RNA (shRNA)17-19 might 
promote termination as well as transcript release from coligo 
templates, and if shRNA could be made from coligos. We 
therefore made an shRNA-type coligo by deleting all of the 
unpaired nucleotides in the stem of coligo 19aTAR (Fig. 4A), 
a well-transcribed coligo based on miR19a,8 producing coligo 
19anbm34. To test the variable of perfectly base-paired stem 
length on transcription efficiency, we made a homologous series 
with shorter stems (19anbm29, -23 and -19). Each of these coligos 
contains the larger loop of 19aTAR, where transcription initiates 
and terminates in that coligo. The 19aTAR loop appeared to 
initiate significant amounts of transcription in this context, but 
none of the coligos were transcribed into the expected full-length 
RNA hairpins (Fig. 4B, brackets indicate full-length monomer 
size). Instead, transcription appeared to proceed only half-way 
around the coligo (19anmb34 and -29) or slightly more (-23 and 
-19), with substantial amounts of smaller abortive transcripts 
evident. (Note that the linear forms have the intact initiation 
loop as well, and were transcribed similarly.) This experiment 
revealed that internal loops and bulges are necessary for coligo 
transcription into full-length monomer transcripts.
We next added back the internal loops and bulges, either 
from the direction of the larger loop (LL), closer to the expected 
initiation site, or from the direction of the smaller loop, which 
encodes the apical loop of the hairpin transcript (Fig. 4A). 
Adding back the internal loops from the direction of the larger 
loop first partially (19anb-BR1), then fully (-BR2) restored full-
length transcription (Fig. 4C), but adding back the bulges to the 
other end of the stem (19anb-BR3, -BR4, -BR5) did not restore 
full-length transcription. In the latter three cases, transcription 
appeared to proceed well until the start of the perfectly base-
paired shRNA stem was encountered from the direction of the 
smaller loop, where transcription appeared to stop abruptly 
(Fig. 4A, D; lanes 23–25; 50, 60 and 67 nt counting from 
predicted TSS). Thus, throughout the 19anb series shown in 
Figure 4, transcription appeared to initiate well in the larger loop 
and transcribe at least to the smaller loop or a little beyond. These 
results indicate that shRNA-encoding coligos will likely only be 
useful if some mismatched nucleotides can be introduced into 
the stem close to the larger loop, perhaps in the form of dA-dC 
mismatches to produce rG-rU base pairs in the shRNA.
Linear vs. circular templates, and the point of circularization
The results shown in Figure 4B and C contained an unexpected 
observation: the linear templates were transcribed nearly as 
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well as their circular counterparts. This result was particularly 
unexpected for coligo 19anb-BR2 because both linear and 
circular forms gave rise to full-length monomer transcripts 
(Fig. 4C, lanes 19, 20). In contrast, previous work indicated 
that the circular topology of the coligo was necessary for the 
production of discrete full-length monomer transcripts by RNAP 
III.8 In previously studied coligos, like 19aTAR (Fig. 4A) and 
122 (Fig. 1), we had circularized the linear templates in terminal 
loop regions using TS2126 RNA ligase, which does not require 
structural juxtaposition of the 5′ and 3′ ends within a helix,20,21 
but each of the new coligos in Figure 4A was circularized in a 
ds region using T4 DNA ligase. Moving the ligation site to a 
helical region gives the linear form of the sequence a predicted 
coligo-like secondary structure, including an intact larger loop, 
where transcription appears to initiate. Transcription beginning 
in the larger loop of the linear form should however “run off” 
at the nick (Fig. 4A, black triangles), producing transcripts that 
cannot be as long as the intact coligo’s full-length monomer 
Figure 5. coligo linear precursors nicked in a helical region are transcribed like intact coligos. (A) T4 DNa ligase assay to verify dephosphorylation of the 
19anb-BR2 linear precursor. LOh, dephosphorylated linear precursor; LP, 5′ phosphorylated linear precursor. DNa visualized by stains-all after DPaGe. (B) 
IVT of 100 nM 19anb-BR2 templates (LP, LOh, c) using heK293T Wce or IP’d RNaP III. coligo 122 was used as a positive IVT control. The relative amounts 
of monomer transcripts (boxed) were calculated separately for IP’d RNaP III and heK293T Wce and normalized within each gel to coligo templated 
transcripts. R.I., relative exposure intensity of image. (C) Input templates were recovered from heK293T Wce IVT reactions and visualized by stains-all 
after DPaGe. RNase a was used to clarify results by degrading endogenous RNa. (D) about 1% of LP 19anb-BR2 is circularized by IP’d RNaP III beads. 5′ 
32P labeled 19anb-BR2 linear precursor DNa was examined at the end of an IP’d RNaP III IVT reaction (lanes 1–9). c1 is a gel mobility standard for coligo 
19anb-BR2; L2 is a linear ligation dimer. Bsa negative control substituted Bsa protein for Wce during IP. No aTP lane is a negative control for DNa Ligase 
activity on the IP’d RNaP III beads. s1 Nuclease treatment (s1N) of c1 and L2 isolated from a T4 DNa ligase reaction on 5′-32P labeled linear precursor was 
used to check for circularization (lanes 10–17). Insets are longer exposures of boxed gel regions. (E) control IP from unmodified heK293T cell Wce also 
contained a contaminating DNa Ligase activity, indicating that the contaminating ligase activity is not RNaP III -dependent. (F) IP’d RNaP III IVT as a 
function of coligo 19anb-BR2 concentration. The 1 nM lane (lane 6, 0.06 relative RNa produced) represents the amount of circularized linear precursor 
formed by contaminating DNa ligase activity during IP’d RNaP III IVT. It cannot account for the amount of transcript formed by 100 nM linear template 
(lane 3, 0.61 relative RNa).
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transcripts. We considered two possible explanations: either the 
polymerase could jump, i.e., transcribe through, the nick, as T7 
RNA polymerase can do,22,23 or a DNA ligase in the WCE was 
first circularizing the linear form to produce the coligo in situ, 
followed by coligo transcription. Because circularity has been a 
defining coligo feature, we tested for in situ circularization.
Figure 6. conversion of poorly transcribed coligos into productive templates. (A) Predicted secondary structures of coligos used in Panels B and c. Luc-2 
series: The terminal loops from coligo 122 were used to replace those of coligo luc-2. 19a series: stepwise changes made to poorly transcribed coligo 19a, 
including removal of its large internal loop, replacement of its loops with those from 122, and mutation of the da4 RNaP III termination sequence in the 
19a stem (circled G). Tss, transcription start site; stop, predicted transcript 3′ end site; black triangles, circularization sites; nt, nucleotides; sL, 122’s small 
terminal loop; LL, 122’s large terminal loop; lines over sequence indicate known RNaP III termination sequences. (B) IVT of 100 nM Luc-2 series coligos 
in heK293T Wce. (C) IVT of 100 nM 19a series coligos in heK293T Wce. Lines on gel mark a 10 nt window centered on the predicted size for monomer 
transcripts based on the 122 large loop Tss. arrows to the right indicate transcripts suspected to terminate at the da4 sequence in the coligo stem, and 
which disappear when da4 is changed to d(aaGa). coligo 122 used as a positive coligo control. M, marker; L, linear precursor; c, coligo.
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We made linear versions of 19anb-BR2 with and without the 
5′ phosphorylation required for DNA ligase (Fig. 5A, LP and LOH), 
then performed in vitro transcription in WCE and IP’d RNAP 
III (Fig. 5B). In WCE, all three versions of the 19anb-BR2 
sequence gave rise to full-length monomer transcripts. LOH was 
the least efficient template, leading us to suspect that in WCE 
linear oligonucleotides with this type of secondary structure can 
be sequentially 5′ phosphorylated and ligated by endogenous 
enzymes before undergoing transcription by WCE RNAP III. 
The lag time taken to prepare the coligo in situ would reduce the 
time available for transcription; hence, less RNA is made when 
the in vitro reaction begins with the linear templates.
Surprisingly, IP’d RNAP III, which should have no appreciable 
5′ kinase and ligase activities remaining, gave a similar result 
(Fig. 5B, right). To examine the fate of the oligonucleotides, 
we scaled up the in vitro transcription reactions and stained 
the recovered linear and coligo templates after resolution on a 
denaturing polyacrylamide gel (DPAGE) (Fig. 5C). RNase A 
treatment was used to clarify the results by removing cellular RNA. 
The linear versions had indeed been mostly (LP) or partially (LOH) 
circularized in WCE, consistent with our explanation for their 
transcriptional behavior in WCE. Since little or no circularization 
was found in the IP’d RNAP III reactions, despite the similar 
transcription results, a more sensitive technique was used to look 
for circularization. We examined the DNA at the end of an IVT 
reaction using IP’d RNAP III and the linear, 5′ phosphorylated 
19anb-BR2 precursor sequence containing a trace of 5′-32P label 
(Fig. 5D). This experiment revealed small amounts of two new 
ATP-dependent products, including one (C1) confirmed by 
gel mobility and S1 Nuclease nicking conditions24 to be coligo 
19anb-BR2 (Fig. 5D). Coligo 19anb-BR2 formed in situ by 
IP’d RNAP III amounted to only ~1% of the input linear oligo. 
The other product, L2 (Fig. 5D) had the same gel mobility as 
one demonstrated by S1 Nuclease nicking conditions to be the 
linear dimer (trace amounts of minor linear and circular ligation 
multimers can be formed by T4 DNA ligase, see Figure 5D, 
lane 11). A control immunoprecipitation from untransfected 
HEK293T WCE contained the same ligase activity (Fig. 5E), 
showing that the ligase activity was a contaminant adhering 
non-specifically to the FLAG IP beads, rather than an activity 
associated with the IP’d RNAP III. We next asked if 1% (i.e., 1 
nM coligo) of the 100 nM linear 5′ phosphorylated 19anb-BR2 
input - the amount of coligo 19anb-BR2 estimated to form 
in situ - could account for the amount of transcript produced 
by linear 19anb-BR2 (Fig. 5F). This amount of coligo (1 nM) 
produced 10-fold less RNA than did the linear coligo precursor 
at 100 nM (Fig. 5F, lane 3 vs. 6). Thus, the amount circularized 
in situ does not account for the amount of full-length monomer 
transcripts observed from linear 19anb-BR2 in the IP’d RNAP 
III IVT reaction. Although transcribing through the nick 
seems to us less likely, we cannot rule it out, and both processes 
likely contribute to the unexpected transcription of the linear 
19anb-BR2 sequence.
Improving transcription from poorly transcribed coligos
Coligos would prove useful if they could serve as a platform 
technology for expressing RNA hairpins in cells. We therefore 
asked whether some of the features of coligo 122 (Fig. 6A), 
our best-transcribed example, could be used to promote the 
transcription of other hairpins. Transcription of coligo 122 
begins and ends in its larger loop.8 We took coligo luc-2, which 
transcribed poorly in WCE, and replaced its smaller and larger 
loops with those from 122 (Fig. 6A). When both loops were 
added, transcription was markedly improved (Fig. 6B). However, 
the pattern was not as homogeneous as that for 122 itself, possibly 
because the dAAACA RNAP III termination signal at the stem-
loop junction of 122 was not preserved in creating mut2A and 
mut2B.
We next applied, with additional modifications, a similar 
strategy to another poorly transcribed coligo, 19a.8,21 This 
coligo has a large A- and C-rich internal loop which we 
suspected might be providing unwanted internal initiation 
sites. Preliminary evidence from an RLM-RACE experiment8 
indicated transcription initiation at this site in the closely related 
coligo 19aTAR (see Tss arrow on the 19a sequence, Fig. 6A). 
We reduced the size of this internal loop to form coligo 19a-
rb (Fig. 6A), and this change led to the loss of most transcripts 
(Fig. 6C, lane 10). We then replaced 19a’s larger loop with the 
122 larger loop (coligo 19a-rb-122L). This change further 
reduced the background of shorter transcripts, but also produced 
a low level of transcripts at the expected size of ~69 nt, though 
unexpectedly, in and of itself, this loop did not confer the strong 
transcription it initiates in 122 (Fig. 6C, lane 11 vs. 8). We 
then swapped the smaller 19a loop for that from 122, which 
changed the smaller loop sequence from AATA to AATTG, 
to form coligo 19a-rb-122LS (Fig. 6A, boxed smaller loop). 
This change led to a significant increase in monomer transcript 
production which, given the modesty of the sequence change, we 
tentatively attribute to increasing the loop size from 4 to 5 nt. 
Coligo 19a-rb-122LS also produced smaller, possibly abortive 
transcripts around 50 nt, which if transcription was initiating 
in the 122 larger loop, would correspond to termination at the 
dA
4
 site in the stem. We increased the amount of sequence taken 
from the smaller 122 loop region, and placed it such that the 
cDNA of the mature miR19a (shaded in Fig. 6A) was not altered 
(coligo 19a-rb7, dotted box). This change did little to improve 
the amount of monomer transcripts, strengthening our suspicion 
that the important feature of the 122 smaller loop is that it is 5 
nt, rather than 4 nt which, when clamped by one or more G-C 
base pairs, might be too small to allow efficient read-through. 
It also appeared to change use of the dA
4
 termination site from 
monomer use (~50 nt) to dimer (~128 nt) and trimer (~206 nt) 
use (Fig. 6C, lane 13, see arrows to the right of the gel). Since 
the increased amount of the 122 smaller loop sequence proved 
not to be critical, we went back to 19a-rb-122LS and changed its 
possible dA
4
 termination site in the stem to dAAGA, to produce 
coligo 19a-rb9. This final change left the cDNA encoding the 
mature 19a intact, and produced RNA having a length consistent 
with mainly monomer hairpin transcripts (~69 nt), appearing 
to begin and end in the 122 larger loop. Destroying the dA
4
 
site by this small change also led to the loss of all transcripts in 
19a-rb-122LS and 19a-rb7 putatively resulting from use of the 
dA
4
 termination site. This transformation of an untranscribed 
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coligo encoding a pre-miRNA-like hairpin to a strongly 
transcribed coligo shows that there are multiple considerations 
in coligo structure that must be taken into account to design 
a productive coligo. One unexpected consideration was that a 
RNAP III termination signal in the stem can in fact be used by 
the polymerase –it appeared not to be used in coligo 19aTAR 
(Fig. 4) – causing unwanted termination there, and also appearing 
generally to reduce the level of coligo transcription. We note that 
to be observed at the end of an in vitro transcription reaction 
in extracts, transcripts likely have to meet two requirements: 
(1) transcription initiation and termination by RNAP III, and 
(2) a hairpin structure conferring resistance against nucleases. 
Termination at a dA
4
 in the stem may not allow completion of a 
hairpin, leading to unstable transcripts that are quickly degraded.
Coligo transcript processing by Dicer
If coligos are to be suitable for use as vectors for the ectopic 
expression of miRNA or siRNA, they will need to template the 
production of pre-miRNA hairpin mimics that can be processed 
by the enzyme Dicer.25,26 We previously found evidence supporting 
the expectation that coligo transcripts carry 5′ triphosphates.8 In 
some organisms, Dicer requires a 5′ triphosphate for complete 
processing,27 but human Dicer substrates, the products of 
Drosha processing, carry a 5′ monophosphate.28,29 It is not 
known if cleavage by human Dicer will be affected by a 5′ 
triphosphate,30 but shRNAs made from RNAP III promoters 
undergo processing to functional siRNA.17 We have observed in 
some cases what might be processing products in the 19–24 nt 
range (e.g., Fig. 2D, 221; Fig. 6B, mut2A, mut2B) but in many 
cases we have not observed any possible Dicer products, or have 
been unable to discern processing due to abortive transcription 
products. In an initial effort to assess the possibility of Dicer 
processing, we transcribed four miRNA-encoding coligos using 
HEK293T WCE in the presence of recombinant Dicer (rDicer) 
IP’d from transiently transfected HEK293T cells. The tested 
coligos included two based on miR-21 and miR-143 (Fig. 7A). 
Supplementing endogenous Dicer in this way led to modest 
increases in putative Dicer products (19–24 nt) for three of the 
four coligos (Fig. 7B, lanes 2, 4 and 8). To further clarify this 
result, we gel purified the transcript from 122 and treated it 
with the IP’d rDicer (Fig. 7C). Products having sizes consistent 
with Dicer processing were observed (Fig. 7D). Thus, hairpin-
encoding coligos can give rise to Dicer substrates, raising the 
possibility that coligos can be used to produce RNAs that enter 
the siRNA or miRNA processing pathways.
Discussion
Small RNA expression vectors can provide an alternative 
to chemically synthesized small RNA, for example siRNA 
and miRNA mimics, in experimental and therapeutic 
applications.17,31-33 Here we continue our development of small 
RNA expression vectors able to use a cell’s own RNAP III to 
make small RNA hairpins from information contained in 
chemically synthesized DNA. We previously described the basic 
anatomy of an RNA hairpin-encoding coligo: an imperfectly 
base-paired stem capped by two ss loops, the larger of which 
is purine-rich and provides a transcription initiation site at a 
pyrimidine near the stem-loop junction.8 Here we extend and 
refine the determinants of coligo transcription. One important 
conclusion is that, while important, the larger loop is not the 
Figure 7. coligo transcript processing by Dicer. (A) sequences and predicted secondary structures of two additional coligos used for IVT in the pres-
ence of recombinant human Dicer. shaded regions indicate cDNa of mature miRNa 21 and 143. Tss, predicted transcription start site; LL, larger loop; 
black triangle, circularization site; nt, coligo sizes in nucleotides. (B) heK293T Wce IVT in the presence or absence of supplemental recombinant Dicer 
(rDcr). Bracket indicates gel region containing expected monomer transcripts. M, marker; L, linear precursor; c, coligo. (C) DPaGe analysis of an in vitro 
processing reaction between coligo 122’s purified monomer transcript and FLaG-Dicer immunoprecipitated from transiently transfected heK293T cells. 
(D) Predicted secondary structures of coligo 122 and its monomer transcript, with deduced Dicer cut sites indicated.
www.landesbioscience.com Transcription e27913-11
sole determinant of transcription. For the larger loop to function 
optimally, it is important (1) to avoid large internal loops that 
can provide secondary initiation sites, (2) to avoid the dA≤4 
termination sequence16 in the stem, (3) to ensure that the smaller 
loop is at least 5 nt, and (4) that unpaired nt be included in the 
stem, especially near the larger loop. When swapping loops, we 
also note that it is important to use a program like mfold14 to 
ensure that the coligo structure is maintained, since changing 
loop sequences can sometimes change the basic coligo structure 
substantially. Overall, the coligos tested here afford new insights 
into the design of productive hairpin-encoding RNAP III 
templates, though more work remains to be done to understand 
how the stem-larger loop junction affects the final 5′ and 3′ end 
formation precision.
Coligos are by definition covalently closed circular 
oligonucleotides. Previous work demonstrated that circularization 
conferred stability against exonucleases and appeared to 
promote transcription initiation at a small number of sites 
near the stem-larger loop junction. Coligo linear precursors 
discontinuous in the larger loop were poorly transcribed and 
suffered degradation in WCE during in vitro transcription.8 
Surprisingly, when the precursor’s point of discontinuity was 
moved from the unstructured larger loop to a helical region in 
the stem, the linear and coligo templates gave similar full-length 
monomer transcription products (Fig. 4). This behavior might 
be explained in the WCE case by the finding that linear coligo 
precursor sequences were circularized by a cellular ligase in the 
extract (with, presumably, 5′ phosphorylation when starting with 
the unphosphorylated precursor), after which they underwent 
coligo transcription. The same pre-transcription events occurred 
to a lesser extent on IP’d RNAP III, due to small amounts of 
kinase and ligase activities adhering to the IP beads, but these did 
not produce enough coligo to explain the amount of transcripts 
formed by the linear template. This discrepancy would be resolved 
if RNAP III is able to transcribe through a nick in the template 
strand DNA, or at least run-off at the nick and then resume 
with priming by the nascent transcript. Our observation that 
IP’d RNAP III produced more full-length transcript from a 5′ 
phosphorylated linear precursor than from an unphosphorylated 
precursor supports the sequential phosphorylation, circularization 
and coligo transcription on the IP beads, but this explanation 
alone cannot account for all of full-length monomer transcript 
made from the nicked form of coligo 19anb-BR2. Our results do 
not allow us to rule out the possibility that RNAP III transcribes 
across the nick while that part of the DNA is functioning as the 
template strand. These two processes are not mutually exclusive, 
and each may contribute to the apparent circumtranscription of 
the linear 19anb-BR2 template by IP’d RNAP III. In any case, 
our results show that the linear precursor of the coligo sequence 
can be stabilized in WCE by placing the discontinuity in a helix 
(Fig. 5C), and raise the possibility that the circularization step, 
to produce the coligo, like the transcription step, to produce the 
RNA, may be left to cellular enzymes if coligo precursors nicked 
in a helix can be stabilized in serum and cells.
In this work we made use of IP’d RNAP III in vitro to 
confirm that RNAP III is the coligo-transcribing polymerase, 
and to determine whether coligo transcripts pause or terminate in 
vitro. Removing the endogenous cellular small RNA background 
that has hampered our efforts to sequence coligo transcripts 
may in addition provide the basis for a coligo transcript-
specific sequencing protocol. IP’d RNAP III behaved much 
like the endogenous enzyme, confirming the identity of the 
coligo-transcribing polymerase, but produced slightly different 
transcript patterns for some coligos tested (Fig. 2). For example, 
the IP’d enzyme produced a higher background of abortive 
transcripts and a reduced tendency to terminate at the end of 
one circumtranscription. These differences could result from the 
loss during precipitation of one or more loosely held polymerase 
subunits contributing to elongation and termination, respectively. 
Alternatively, abortive transcripts might appear to be more 
abundant if immunoprecipitation removed exonucleases that 
degrade them in WCE. Regarding the difference in termination, 
ss DNA-binding proteins in WCE might bind to the coligo larger 
loop and increase termination by steric obstruction of RNAP III. 
One might also expect ss DNA binding proteins to compete with 
initiating RNAP III for access to the larger loop. These behaviors 
were in fact observed in Figure 2D for some coligos (luc-1, 
-2 and Dcr3) but not for others, raising the possibility that ss 
DNA binding proteins can, for better or worse, modulate coligo 
transcribability in some cases.
Though the IP’d RNAP III appeared to release terminated 
transcripts instead of pausing, we note that our in vitro 
transcription reactions are performed for 90 minutes, which may 
be too long to distinguish between pausing and true termination. 
Nevertheless, on ds DNA templates RNAP III normally has a 
strong tendency to terminate directly after a hairpin followed 
by a polyU sequence.15 Though we have not sequenced the 
new coligo transcripts presented here, the observed size of the 
monomer transcripts were generally consistent with coligo 
transcription initiating and terminating in the larger loop, with 
termination taking place just after completion of the encoded 
hairpin stem, as found previously by sequencing 122’s main 
monomer transcript.8 Most of our coligos have strong or weak 
RNAP III termination pentamers in or near the larger loop. 
It is reasonable to expect they can play a role in termination 
because coligos lacking such sequences, e.g., mut2B (Fig. 6), 21 
and 143 (Fig. 7), produced more tandem multimer transcripts 
in WCE than those that have termination sequences. Yet, even 
the coligos lacking a termination pentamer showed significant 
termination after one circumtranscription. It is therefore likely 
that for hairpin-encoding coligos, a termination signal is not 
absolutely required, but can increase termination efficiency when 
it is close to or overlapping with the end of the hairpin stem, as in 
coligos 122 and apparently in 221. Trimming that is too rapid to 
observe by our methods from an initial ss 3′ extension back to the 
hairpin stem is also a possibility, and may be responsible for some 
differences in the transcript patterns in the IP’d polymerase, but 
some coligos, like 122 and 221, showed almost no difference 
between the WCE and IP’d polymerase sources, indicating that 
trimming cannot be universal.
In conclusion, the in vitro transcription of a new set of coligos 
based mostly on pre-miRNA hairpins and shRNA has allowed 
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us to further characterize the determinants of promoterless 
transcription of this new and unique type of chemically 
synthesized small RNA expression template. In addition to 
developing a much-needed sequencing protocol exploiting 
the IP’d RNAP III, future work will aim to find larger-loop 
sequences preferred by RNAP III, and to optimize the precision 
of initiation and termination, which may in turn lead to optimal 
processing by structure-dependent nucleases like Dicer.
Materials and Methods
Coligo preparation
5′ phosphorylated synthetic linear DNA Ultramer® 
oligonucleotides were purchased from Integrated DNA 
Technologies. Coligo secondary structures were predicted 
using the mfold program.14 Circularization of coligo precursors 
discontinuous in regions predicted to be ss (122, 19aTAR, 
221, 19am3, luc-1, luc-2, Dcr3, 15a-b, 19a, mut2A, mut2B, 
19a-rb, 19a-rb-122L, 19a-rb-122LS, 19a-rb5, 19a-rb7, 19a-
rb9) was performed using TS2126 RNA ligase enzyme as 
previously described.21 5′ phosphorylated nicked dumbbell or 
dumbbell-like linear DNA Ultramers (19anbm19, 19anbm23, 
19anbm29, 19anbm34, 19anb-BR1, 19anb-BR2, 19anb-BR3, 
19anb-BR4, 19anb-BR5) were circularized using T4 DNA ligase 
enzyme (New England BioLabs, NEB, M0202S) and purified 
as described below. Unphosphorylated coligo precursors used in 
Figures 5A-C were made by dephosphorylating the purchased 
Ultramer oligo using Calf intestinal alkaline phosphatase 
(Promega, M182A) according to the manufacturer’s instructions. 
Similarly, 5′ [γ-32P]-ATP labeling of dephosphorylated linear 
Ultramer for Figures 5D and E was done using T4 Polynucleotide 
kinase (NEB, M0201S) according to the manufacturer’s 
instructions.
Whole cell extract (WCE) preparation
HEK293T cell culture was performed as described.8 
HEK293/POLR3F cells were grown under puromycin selection 
as described.13 To prepare the extract, 500 μl of chilled WCE 
lysis buffer [10mM HEPES pH 7.9, 1.5mM MgCl
2
, 10mM KCl, 
0.05% NP40, 0.2 mM EDTA, 0.3M NaCl, 15% Glycerol, and 
Protease Inhibitor Cocktail (Roche, 04693159001)] was added 
per 10 cm dish and the extract was prepared exactly as described.8 
Three plates of either cell type yielded ~1400 μl WCE with a 
total protein concentration of ~3–4 μg/μl compared with bovine 
serum albumin (BSA) as the standard.
Immunoprecipitation of RNAP III complex
HEK293/POLR3F cells were kindly provided by Dr. James 
Chen (U.T. Southwestern). FLAG® Immunoprecipitation Kit 
(FLAGIPT1, Sigma-Aldrich) was used for immunoprecipitation 
of the RNAP III complex. 40 μl of drained ANTI-FLAG 
M2-Agarose Affinity Gel were used per 1400 μl of WCE 
(HEK293T or HEK293/POLR3F). The beads were pre-washed 
3X with 500 μl 1X Sigma wash buffer. The WCE was added to 
the beads and gently rocked at 4 °C for 2 h. The supernatant 
(“Sup” in Fig. 2A and B) and immunoprecipitated (IP’d) RNAP 
III complex were separated by centrifugation. The IP’d RNAP III 
was washed 3X with 500 μl of WCE lysis buffer. The final wash 
was stored (“Wash” in Fig. 2B) and the RNAP III bound beads 
were resuspended in 160 μl (200 μl final) of WCE lysis buffer. 
For elution of RNAP III complex from the beads, after the final 
wash the IP’d beads were resuspended in 80 μl of elution buffer 
(WCE lysis buffer with 190 ng/μl FLAG peptide) and incubated 
for 1 h with gentle rocking at 4 °C. The supernatant containing 
the RNAP III complex was collected by centrifugation and 
transferred to a new pre-chilled microfuge tube. The beads were 
again resuspended in 80 μl of WCE lysis buffer, centrifuged and 
the supernatants were pooled. The volume of eluted RNAP III 
complex was finally adjusted to 200 μl by adding WCE lysis 
buffer and stored at -80 °C. After elution, the beads (Post IP in 
Fig. 2B) were resuspended in WCE lysis buffer to a final volume 
of 200 μl and stored at -80 °C. For BSA controls experiments 
(Fig. 2C, 5D and E) an identical immunoprecipitation procedure 
was followed but BSA was used in place of WCE.
In vitro transcription (IVT)
IVT using the linear or circular templates, WCE or 
immunoprecipitated RNAP III complex, and uniform label 
incorporation with [α-32P]-UTP was performed as follows. A 
typical 20 μl reaction contained 4 μl (~16 μg) of WCE (0.28% 
of an entire 1400 μl WCE preparation), 8 U RNasin® RNase 
inhibitor (N2515, Promega), 0.6 mM each ATP, GTP, CTP, 0.2 
mM UTP, ~2 μCi [α-32P]-UTP, 40 mM TRIS-HCl pH 7.9 (at 25 
°C), 6 mM MgCl
2
, 10 mM DTT, 2 mM spermidine, and 100 nM 
DNA template unless otherwise indicated. For IVT performed 
using immunoprecipitated RNAP III complex (IP, elution, post 
IP), 4 μl was used per IVT reaction which corresponds to 2% of 
an entire 1400 μl WCE preparation. For IVT reactions done cold 
without uniform [α-32P]-UTP labeling (Figs. 5C, 5D, and 5E), 
the [α-32P]-UTP was replaced with an equivalent amount of cold 
UTP. Transcription reactions were incubated for 90 min at 37 °C 
followed by extraction with TRIzol® reagent (Invitrogen, 15596–
026) and precipitation following manufacturer’s instructions. 
Precipitated RNA and/or 5′ labeled coligo linear precursors were 
separated on a 10% denaturing polyacrylamide electrophoresis 
gel (DPAGE) including 40% formamide (Fig. 5D and 5E) or 
without formamide (all other gels), and visualized by exposing 
the dried gel to a Molecular Dynamics Phosphorimager Screen. 
Image quantification was performed using MD ImageQuant 
software.
Western blotting
Western blotting of RPC2 shown in Figure 2C was performed 
as previously described.8 The WCE and IP’d RNAP III samples 
used for western blotting were from a different but identically 
prepared batch than the one used for the IVT in Figure 2A 
and B, and the IVT activity was assayed and found to be identical 
before using for western blotting (not shown). The amount 
of RNAP III (WCE or IP beads) normally used for IVT was 
doubled for western blotting. Rabbit anti-RPC2 (Bethyl Labs 
Inc. A301–855A) and goat anti-rabbit (Calbiochem, DC03L) 
were used as primary and secondary antibodies respectively for 
RPC2. Similarly, mouse monoclonal anti-RPB1 CTD (Covance 
8WG16) and goat anti-mouse (Calbiochem DC08L) were used 
as primary and secondary antibodies respectively for detection 
of the RNA Polymerase II (RNAP II) RPB1 CTD. The goat 
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anti-mouse antibody recognizes mouse anti-FLAG antibodies 
shed from IP beads, producing 8WG16-independent signals on 
the RPB1 blot, denoted by asterisk in Figure 2C.
T4 DNA ligase circularization
Preparative T4 DNA ligase reaction for circularization of 
dumbbell or dumbbell-like linear precursors was performed 
as follows (500 μl final reaction volume): 500 pmol of linear 
5′ phosphorylated precursor sequence was incubated in 1X T4 
DNA ligase buffer at 94 °C for 3 min and slow-cooled to 50 °C, 
then put at room temperature and then at 18 °C. 1000 units of 
T4 DNA ligase and 1 mM final ATP was added and left at 18 °C 
for 2 h. DNA was extracted using phenol:choloroform:isoamyl 
alcohol (PCI) and ethanol precipitated. Uncircularized precursor 
was removed by Exonuclease III (M181A, Promega) treatment 
using the manufacturer’s protocol, or by gel purification of the 
circularized product as previously described.21 The small-scale 
analytical T4 DNA ligase reaction shown in Figure 5A was done 
similarly but in 20 μl containing 10 pmol of linear template 
and 40 units of the enzyme. Extracted DNA was visualized 
by staining with Stains-all (7423–31–6, Acros) as previously 
described.8 Similar conditions were used for circularization of 5′ 
radiolabeled linear 19anb-BR2 template as shown in Figure 5D 
and E without staining.
Template recovery from IVT reactions
As shown in Figure 5C, each reaction was scaled up 4-fold 
compared with typical IVT reaction described above to ensure 
visualization of the templates by Stains-all dye. After IVT 
reaction, each sample was PCI extracted and ethanol precipitated. 
The samples were further treated +/- RNase A for additional 30 
min at 37 °C. Nucleic acids were isolated again by PCI extraction 
and ethanol precipitation, run on 10% DPAGE and stained with 
Stains-all as previously described.8
S1 nuclease Assay
The circular topology of the coligos used for IVT reactions 
was verified as previously described21 but with following 
differences: 50 μl reaction volume containing 15 pmol of circular 
oligodeoxynucleotide was treated with 5 units of S1 Nuclease 
(70019, USB). The topology of gel-purified products from 
T4 DNA ligase reaction of 5′ radiolabeled linear 19anb-BR2 
(Fig. 5D) was also verified similarly using S1 Nuclease. The bands 
were visualized and quantified by exposure to Phosphorimager 
screen and MD ImageQuant software.
Purification of recombinant Dicer complex
For purification of recombinant human Dicer (rDicer), 
a FLAG-tagged Dicer plasmid (Addgene plasmid 19881, 
pFRT/TO/FLAG/HA-DEST DICER34) was transfected into 
HEK293T cells: 2.4x106 cells per 10 cm dish were seeded the 
day before transfection and transfected with 8 μg of the purified 
rDicer plasmid using 80 μl PolyFect transfection reagent 
(Qiagen, 301105) according to the manufacturer’s protocol. 48 
h after transfection, the dishes were washed twice with ice-cold 
1X PBS, and rDicer was purified using Sigma’s FLAG-IP kit 
(FLAGIPT1, Sigma-Aldrich). Briefly, the cells were lysed in 0.8 
ml ice cold lysis buffer supplemented with Protease Inhibitor 
Cocktail (PIC) (04693132001, Roche). The cells were scraped 
with a chilled cell-scraper, transferred into pre-cooled 1.5 ml 
tubes and incubated on ice for 15 min with three vortex pulses 
every 5 min. The lysate was spun for 10 min at 12000 x g at 4 °C 
and the supernatant was transferred to a new, chilled tube. To 
immunoprecipitate FLAG-tagged rDicer, 50 μl of anti-FLAG-
M2-agarose affinity resin suspension (around 25 μl of packed 
bead volume) per 10 cm dish were washed five times with ice 
cold wash buffer in order to remove all traces of storage solution 
with centrifugation at 6000 x g for 30 s at 4 °C in between. 
After the last wash, beads were resuspended in 200 μl lysis 
buffer per 10 cm dish supplemented with PIC and added to the 
cell extract. The extract was rotated for at least 4 h or overnight 
at 4 °C. The beads-rDicer complex was spun for 30 s at 6000 
x g, 4 °C, and then washed 5 times with ice cold wash buffer 
(1.2 ml per wash per 10 cm plate). The rDicer-beads complex 
was resuspended in 60 μl lysis buffer supplemented with PIC 
and 10% Glycerol and stored at -20 °C up to four months. As 
negative control (-rDcr lanes, Fig. 7B), cells were transfected 
with empty pcDNA3.1 vector and treated in exactly the same 
way as the rDicer-transfected dishes.
In vitro transcription in the presence of recombinant Dicer
In vitro transcription in the presence of rDicer-beads was 
performed exactly as described8 but with the addition of 3 μl 
purified rDicer-beads to the 20 μl IVT reaction volume. During 
the 90 min incubation, the tubes were flicked every 15–20 min 
to resuspend beads. RNA extraction and DPAGE was performed 
as described.8
Dicer processing assay for coligo-generated transcripts 
(Fig. 7C)
The body-labeled coligo 122 monomer transcript from a 
4-fold scaled up IVT reaction (see above) in HEK293T WCE 
was purified by 10% DPAGE and extracted from the gel. Half 
of the RNA was then treated with bead-bound FLAG-Dicer 
immunoprecipitated from whole cell extract from HEK293T 
cells transiently transfected with the plasmid expressing FLAG-
Dicer. The processing reaction was performed in Dicer IP assay 
buffer (10 mM Tris pH 7.5, 5 mM MgCl
2
, 1mM DTT, 0.4U/μl 
RNasin, 1 mM ATP)35 for 60 min at 37 °C. RNA was extracted, 
ethanol precipitated and fractionated on 10% DPAGE.
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